Researchers continue to excited about the medication , a novel dual agonist showing remarkable data in initial trials for weight reduction . It functions by modulating several pathways : GLP-1 and GIP, https://umairroik488206.bloggip.com/41160879/this-new-prospect-for-weight-loss